Skip to main content

Table 2 Key indicators for help seeking and access to malaria treatment in individuals with fever in the preceding two weeks

From: Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania

Indicator Children
(N = 80)
Adults
(N = 57)
P*
  n % (95% CI) TDHS2 n % (95% CI)  
Episodes treated 80 100 (95.5–100)   57 100 (93.7–100)  
Medications and dosaging: 1
Modern medicine 80 100 (95.5–100)   56 98.3 (90.6–100) 0.416
Antimalarial drug (AM) 71 88.8 (79.7–94.7) 58.2 (88.6) 47 82.5 (70.1–91.3) 0.293§
- SP 38 47.5 (36.2–59.0) 23.7 (33.8) 25 43.9 (30.7–57.6) 0.673§
- SP correctly dosed 13 16.25 (8.9–26.2)   18 31.6 (19.9–45.2) 0.035 §
- amodiaquine 10 12.5 (6.2–21.8) 22.1 (29.3) 5 8.8 (2.9–19.3) 0.491§
- amodiaquine correctly dosed 5 6.3 (2.1–14.0)   3 5.3 (1.1–14.6) 1.000
- quinine 43 53.8 (42.2–65.0) 11.9 (23.5) 23 40.4 (27.6–54.2) 0.122§
- other AM 2 2.5 (0.3–8.7)   1 1.8 (0.0–9.4) 1.000
Antipyretic only 9 11.3 (5.3–20.3)   9 15.8 (7.5–27.9) 0.438§
Antibiotic 8 10.0 (4.4–18.8)   2 3.5 (0.4–12.1) 0.194
Treatment sources: 1
Health facility visit 61 76.3 (65.4–85.1)   32 56.1 (42.4–69.3) 0.013 §
AM from health facility 43 53.8 (42.2–65.0)   17 29.8 (18.4–43.4) 0.005 §
AM not from health facility 28 35.0 (24.7–46.5)   30 52.6 (39.0–66.0) 0.040 §
AM from drug store 19 23.8 (15.0–34.6)   26 45.6 (32.4–59.3) 0.007 §
AM from general shop 8 10.0 (4.4–18.8)   4 7.0 (2.0–17.0) 0.761
AM from home stock (or relative/neighbour) 10 12.5 (6.2–21.8)   6 10.5 (4.0–21.5) 0.723§
Exclusive home-management with AM3 14 17.5 (9.9–27.6)   18 31.6 (19.9–45.2) 0.055§
  1. 1One episode may be treated with several drugs from various sources; 2Tanzania Demographic and Health Survey 2004–05 (data for Morogoro Region in brackets); 3Episodes never brought to a health facility; * comparison of children and adults; Fisher's exact test; §Chi-square test